Gunma, Japan

Tomoko Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Kirin Beer Kabushiki Kaisha. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoko Watanabe. Retrieved from https://idiyas.com/inventor/tomoko-watanabe-ipiqu0lr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tomoko Watanabe

Introduction

Tomoko Watanabe is a notable inventor based in Gunma, Japan. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative research and development of novel compounds.

Latest Patents

Watanabe holds a patent for isoxazole and thiazole compounds, which are recognized for their excellent lysophosphatidic acid (LPA) receptor antagonistic activity. The patent describes these compounds, represented by a specific general formula, and their potential use as medicine. The compounds include various substituents, allowing for a range of applications in therapeutic settings.

Career Highlights

Watanabe is currently associated with Kirin Beer Kabushiki Kaisha, where she applies her expertise in medicinal chemistry. Her work focuses on developing innovative solutions that can lead to advancements in medical treatments.

Collaborations

Throughout her career, Watanabe has collaborated with talented colleagues, including Akihiro Ueno and Rika Nagao. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the research process.

Conclusion

Tomoko Watanabe's contributions to the field of medicinal chemistry through her innovative patents and collaborative efforts highlight her role as a significant inventor in the industry. Her work continues to pave the way for advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…